Cryomass Technologies (Cryomass Technologies) Forward Dividend Yield % : 0.00% (As of May. 29, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Cryomass Technologies Forward Dividend Yield %?

As of today (2024-05-29), the Forward Annual Dividend Yield of Cryomass Technologies is 0.00%.

As of today (2024-05-29), the Trailing Annual Dividend Yield of Cryomass Technologies is 0.00%.

CRYM's Forward Dividend Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.87
* Ranked among companies with meaningful Forward Dividend Yield % only.

Cryomass Technologies's Dividends per Share for the three months ended in Sep. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Cryomass Technologies's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Cryomass Technologies's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryomass Technologies's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cryomass Technologies's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Cryomass Technologies's Forward Dividend Yield % falls into.

Cryomass Technologies Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Cryomass Technologies (OTCPK:CRYM) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Cryomass Technologies Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Cryomass Technologies's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryomass Technologies (Cryomass Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cryomass Technologies Inc (OTCPK:CRYM) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1001 Bannock Street, Suite 612, Denver, CO, USA, 80204

Website

https://www.cryomass.com

Cryomass Technologies Inc designs, manufactures, and licenses field-mobile equipment for the handling of harvested cannabis, hemp, and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect and protect the high-value compounds from the harvested plant. The company's offerings include refinement systems and monitoring and control systems.

Executives

Philip Blair Mullin	officer: Chief Financial Officer	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Christian Noel	director, officer: Chief Executive Officer	3531 SOUTH LOGAN ST. SUITE D-357, ENGLEWOOD CO 80113
Patricia Izabel Kovacevic	officer: GC, Corp Secy, and Head of EA	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Delon Hannes Human	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mark Radke	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mario Gobbo	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113